5NUM
Engineered beta-lactoglobulin: variant F105L-L39A in complex with chlorpromazine (LG-LA-CLP)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SEALED TUBE |
Source details | OXFORD DIFFRACTION NOVA |
Temperature [K] | 130 |
Detector technology | CCD |
Collection date | 2016-01-19 |
Detector | AGILENT ATLAS CCD |
Wavelength(s) | 1.54 |
Spacegroup name | P 32 2 1 |
Unit cell lengths | 53.328, 53.328, 110.003 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 14.820 - 2.300 |
R-factor | 0.22793 |
Rwork | 0.219 |
R-free | 0.28908 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1bsy |
RMSD bond length | 0.010 |
RMSD bond angle | 1.419 |
Data reduction software | CrysalisPro |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0073) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 15.000 | 2.390 |
High resolution limit [Å] | 2.300 | 2.300 |
Rmerge | 0.074 | 0.576 |
Number of reflections | 8447 | 875 |
<I/σ(I)> | 8 | 1.6 |
Completeness [%] | 99.3 | 99.5 |
Redundancy | 2.8 | 2.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8 | 293 | 2.60 M (NH4)2SO4 in 0.1 M Tris-HCl, pH 8.0 |